Ignite Creation Date:
2024-05-06 @ 1:42 PM
Last Modification Date:
2024-10-26 @ 1:18 PM
Study NCT ID:
NCT04095390
Status:
UNKNOWN
Last Update Posted:
2019-09-19
First Post:
2019-09-16
Brief Title:
A Phase Ⅱ Trial of Pyrotinib Combination With CDK46 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer
Sponsor:
Jinming Yu
Organization:
Shandong Cancer Hospital and Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-08-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-09-16
First Submit QC Date:
September 18 2019
Study First Post Date:
2019-09-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-18
Last Update Post Date:
2019-09-19
Last Update Post Date Type:
ACTUAL